[HTML][HTML] Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates, P Bakke… - European …, 2021 - Eur Respiratory Soc
Rationale There are no validated measures of disease activity in COPD. Since “active”
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates, P Bakke… - European …, 2021 - discovery.ucl.ac.uk
RATIONALE: There are no validated measures of disease activity in chronic obstructive
pulmonary disease (COPD). Since" active" disease is expected to have worse outcomes (eg …
pulmonary disease (COPD). Since" active" disease is expected to have worse outcomes (eg …
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates… - European …, 2021 - experts.nebraska.edu
Rationale: There are no validated measures of disease activity in COPD. Since “active”
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.
B Celli, N Locantore, JC Yates, P Bakke… - The European …, 2021 - europepmc.org
Methods We investigated 1) how changes in relevant clinical variables over time (1 or 3
years) relate to 8-year mortality; 2) whether these variables inter-relate; and 3) if any clinical …
years) relate to 8-year mortality; 2) whether these variables inter-relate; and 3) if any clinical …
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates, PS Bakke, P Calverley… - 2021 - bora.uib.no
Rationale There are no validated measures of disease activity in COPD. Since “active”
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
[HTML][HTML] Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates, P Bakke… - European …, 2021 - Eur Respiratory Soc
Rationale There are no validated measures of disease activity in COPD. Since “active”
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
[HTML][HTML] Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates, P Bakke… - The European …, 2021 - ncbi.nlm.nih.gov
Methods We investigated 1) how changes in relevant clinical variables over time (1 or 3
years) relate to 8-year mortality; 2) whether these variables inter-relate; and 3) if any clinical …
years) relate to 8-year mortality; 2) whether these variables inter-relate; and 3) if any clinical …
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates… - The European …, 2021 - pubmed.ncbi.nlm.nih.gov
Rationale There are no validated measures of disease activity in COPD. Since" active"
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
B Celli, N Locantore, JC Yates… - European …, 2021 - cris.maastrichtuniversity.nl
Rationale: There are no validated measures of disease activity in COPD. Since" active"
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …
disease is expected to have worse outcomes (eg mortality), we explored potential markers of …